High-dose rifamycins enable shorter oral treatment in a murine model of mycobacterium ulcerans disease

Till F. Omansen, Deepak Almeida, Paul J. Converse, Si Yang Li, Jin Lee, Ymkje Stienstra, Tjip van der Werf, Jacques H. Grosset, Eric L. Nuermberger

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'High-dose rifamycins enable shorter oral treatment in a murine model of mycobacterium ulcerans disease'. Together they form a unique fingerprint.

Medicine & Life Sciences